scispace - formally typeset
E

Effat Naimi

Researcher at Baqiyatallah University of Medical Sciences

Publications -  5
Citations -  615

Effat Naimi is an academic researcher from Baqiyatallah University of Medical Sciences. The author has contributed to research in topics: Internal medicine & Autoantibody. The author has an hindex of 4, co-authored 4 publications receiving 481 citations.

Papers
More filters
Journal ArticleDOI

Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis.

TL;DR: Short-term supplementation with curcuminoid-piperine combination significantly improves oxidative and inflammatory status in patients with MetS and could be regarded as natural, safe and effective CRP-lowering agents.
Journal ArticleDOI

Effects of supplementation with curcumin on serum adipokine concentrations: A randomized controlled trial.

TL;DR: Curcumin can improve serum levels of adiponectin and leptin in patients with metabolic syndrome and remained significant after adjustment for changes in serum lipids and glucose concentrations and baseline differences in body mass index.
Journal Article

Th1/Th2 cytokines in patients with Graves' disease with or without ophthalmopathy.

TL;DR: Quantitative-cytokine analysis demonstrated that a combination of Th1 and Th2 cytokines may contribute to the pathogenesis of Graves' disease and indicates that IL-10, but not IL-4, is related to the moderate and severe forms of thyroid associated ophthalmophathy.
Journal ArticleDOI

Correlation of Serum Levels of Interleukine-16, CCL27, Tumor Necrosis Factor-related Apoptosis-inducing Ligand, and B-cell Activating Factor with Multiple Sclerosis Severity.

TL;DR: Higher serum levels of CCL27, BAFF, TRAIL, and IL-16 are found in MS patients with more severe disabilities than mild forms, which may represent their contribution to the pathogenesis of MS.